Literature DB >> 20965695

The use of botulinum toxin type A in cosmetic facial procedures.

G W C Jaspers1, J Pijpe, J Jansma.   

Abstract

Over the past decade, facial cosmetic procedures have become more commonplace in dentistry and oral and maxillofacial surgery. An increasing number of patients seek minimal invasive procedures. One of the most requested procedures is treatment with botulinum toxin type A (BoNTA). Treatment of dynamic rhytids and lines with BoNTA is effective and produces high rates of improvement with rapid onset and long duration of action (longer than 4 months for some patients) compared with placebo. This paper considers the history and pharmacology of this neurotoxin, and focusses on the literature concerning the treatment of different facial areas with BoNTA. It also presents clinical guidelines on the treatment of glabellar lines, the frontalis muscle, peri-orbital lines, gummy smile and masseter muscle hypertrophy. Knowledge about the mechanisms of action and the ability to use BoNTA as an adjunctive treatment are mandatory for those working in the field of cosmetic facial surgery.
Copyright © 2010 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20965695     DOI: 10.1016/j.ijom.2010.09.014

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  20 in total

1.  Management of gummy smile with Botulinum Toxin Type-A: A case report.

Authors:  Sudeeptha Dinker; A Anitha; Abhinay Sorake; Kishore Kumar
Journal:  J Int Oral Health       Date:  2014-02-26

2.  An Evaluation of Use of Botulinum Toxin Type A in the Management of Dynamic Forehead Wrinkles - A Clinical Study.

Authors:  Avvaru Susmita; Naga Neelima Devi Kolli; Sridhar Meka; Srinivas Pandi Chakravarthi; Vivekanand Sabanna Kattimani; Krishna Prasad Lingamaneni; Latheef Saheb Shaik
Journal:  J Clin Diagn Res       Date:  2016-10-01

3.  The effect of botulinum toxin A in patients with excessive gingival display with and without zinc supplementation: randomized clinical trial.

Authors:  Nesma Shemais; Azza Ezz Elarab; Hani ElNahass
Journal:  Clin Oral Investig       Date:  2021-05-05       Impact factor: 3.573

4.  A botulinum toxin-derived targeted secretion inhibitor downregulates the GH/IGF1 axis.

Authors:  Emmanuel Somm; Nicolas Bonnet; Alberto Martinez; Philip M H Marks; Verity A Cadd; Mark Elliott; Audrey Toulotte; Serge L Ferrari; René Rizzoli; Petra S Hüppi; Elaine Harper; Shlomo Melmed; Richard Jones; Michel L Aubert
Journal:  J Clin Invest       Date:  2012-08-01       Impact factor: 14.808

Review 5.  Applications of botulinum toxin in dentistry: A comprehensive review.

Authors:  Sanjeev Srivastava; Smriti Kharbanda; U S Pal; Vinit Shah
Journal:  Natl J Maxillofac Surg       Date:  2015 Jul-Dec

6.  Botulinum toxin related research in maxillofacial plastic and reconstructive surgery.

Authors:  Tae-Geon Kwon
Journal:  Maxillofac Plast Reconstr Surg       Date:  2016-09-05

7.  An Experimental Study on Botulinum Toxin Type A for the Treatment of Excessive Secretion after Submandibular Gland Transplantation in Rabbits.

Authors:  Shang Xie; Hui Xu; Bo Lin; Kan Wang; Xiao-Feng Shan; Zhi-Gang Cai
Journal:  J Ophthalmol       Date:  2016-10-20       Impact factor: 1.909

Review 8.  Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics: Onset and Duration.

Authors:  Mark Nestor; Glynis Ablon; Andy Pickett
Journal:  Aesthet Surg J       Date:  2017-05-01       Impact factor: 4.283

9.  Simultaneous surgery for subcondylar fracture and prominent angle of the mandible.

Authors:  Chang-Hwa Jeong; Jae-Young Ryu; Woo-Yul Lee; Hyeon-Min Kim
Journal:  Maxillofac Plast Reconstr Surg       Date:  2015-08-28

10.  A successful management of sever gummy smile using gingivectomy and botulinum toxin injection: A case report.

Authors:  Diana Mostafa
Journal:  Int J Surg Case Rep       Date:  2017-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.